Sexual function in perimenopausal women treated with relugolix and add back therapy for uterine fibroids: an observational study
Treatment with relugolix-ABT was not associated with statistically significant changes in sexual function, with a good tolerability profile, while effectively reducing the fibroid size and controlling bleeding in most cases.
Authors
- Luca Giuseppe Sgrò
- Lorenzo Novara (ORCID: https://orcid.org/0000-0001-7078-2958)
- Valentina Elisabetta Bounous (ORCID: https://orcid.org/0000-0002-6826-4788)
- Matteo Mancarella (ORCID: https://orcid.org/0000-0002-3367-6758)
- Stefano Pautasso
- Francesco Testa (ORCID: https://orcid.org/0000-0001-9537-9196)
- Marco D’Amore
- Silvia Carignano
- Sara Hussein Aly
- Annamaria Ferrero
Institutions
- A. O. Ordine Mauriziano di Torino (IT)
- University of Turin (IT)
Publication Details
- Journal
- The European Journal of Contraception & Reproductive Health Care
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1080/13625187.2026.2615974
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00